HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hua-Yong Wu Selected Research

Survivin

6/2012Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hua-Yong Wu Research Topics

Disease

1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022
1Neuroinflammatory Diseases
01/2022
1Neoplasms (Cancer)
06/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2012

Drug/Important Bio-Agent (IBA)

1Complement C1q (C1q Complement)IBA
01/2022
1GemcitabineFDA Link
06/2012
1Emodin (Archin)IBA
06/2012
1SurvivinIBA
06/2012

Therapy/Procedure

1Drug Therapy (Chemotherapy)
06/2012
1Therapeutics
06/2012